Nebenwirkungen · Keppra
Keppra 100 mg/ml concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 93–94
HOS-090885 · Präparat HOS-084117
93 Frequency category MedDRA SOC Very Common Uncommon Rare Very rare common Psychiatric Depression, Suicide Completed Obsessive disorders hostility/ attempt, suicide, compulsive aggression, suicidal personality disorder(2) anxiety, ideation, disorder, insomnia, psychotic thinking nervousness/i disorder, abnormal, rritability abnormal delirium behaviour, hallucination, anger, confusional state, panic attack, affect lability/mood swings, agitation Nervous system Somnolence, Convulsion, Amnesia, Choreoathetosis, disorders headache balance memory dyskinesia, disorder, impairment, hyperkinesia, dizziness, coordination gait disturbance, lethargy, abnormal/atax encephalopathy, tremor ia, seizures paraesthesia, aggravated, disturbance in Neuroleptic attention malignant syndrome(3) Eye disorders Diplopia, vision blurred Ear and Vertigo labyrinth disorders Cardiac Electrocardiogra disorders m QT prolonged Respiratory, Cough thoracic and mediastinal disorders Gastrointestinal Abdominal Pancreatitis disorders pain, diarrhoea, dyspepsia, vomiting, nausea Hepatobiliary Liver function Hepatic failure, disorders test abnormal hepatitis Skin and Rash Alopecia, Toxic epidermal subcutaneous eczema, necrolysis, tissue disorders pruritus, Stevens-Johnson syndrome, erythema multiforme
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-04-01T12:51:00Z · SHA-256 0c9c2dbe2cf9e6cd5c8f5c1f489027f4a1e9204a5531ad8b866e3bc0e64b2e72 · Passage 1f3f0540c79fd0f71a93040c57ff1b97a558b052c5eea20b7b38108b500cfc22 · Zeichen 3079–6663 im Abschnitt